切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - ERK - Gap Junctions

17件产品中的 1-10

页面
每页
清除全部
  1. Gap 27
    A1045 Gap 27
     4 Citation
    Target: Gap Junctions
    Summary: 缝隙连接阻断剂
      ≥65.25 mg/mL
      ≥5 mg/mL
  2. Gap 26
    A1044 Gap 26
     8 Citation
    Target: Gap Junctions
    Summary: 间隙连接阻断肽,对应于connexin 43的63-75 aa。
      ≥77.55 mg/mL
      ≥155.1 mg/mL
  3. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  4. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  5. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  6. VRT752271
    B1106 VRT752271
    Target: ERK
    Summary: ERK1/ERK2 inhibitor
      ≥43.3 mg/mL
      insoluble in H2O
  7. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  8. A-674563
    A8616 A-674563
    Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK
    Summary: Akt1 / PKA / CDK2的强效选择性抑制剂
      ≥4.9 mg/mL
      ≥23.8 mg/mL
  9. Carbenoxolone disodium
    A8389 Carbenoxolone disodium
     1 Citation
    Target: Gap Junctions
    Summary: 11β-HSD抑制剂
      ≥30.74 mg/mL
      ≥55.1 mg/mL
  10. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O

17件产品中的 1-10

页面
每页